Skip to main content
. 2023 Mar 7;2023:7768704. doi: 10.1155/2023/7768704

Table 3.

SAEs were reported in patients.

Event n (%) Severity Critical event types Treatment relationship
IVIB 400 mg 2 (1.74)
 Lowing blood oxygen saturation Moderate Endangering life safety Unknown
 Acute anterior wall myocardial infarction Severe Extended hospital stay and endangering life safety Unknown
IVIB 800 mg 3 (2.70)
 Intestinal fistula Moderate Other serious events Not related
 Acute cholecystitis Severe Extended hospital stay and other serious events Not related
 Abdominal infection Severe Extended hospital stay Not related

IVIB: intravenous ibuprofen; SAEs: serious adverse events.